Cargando…
δ-Aminolevulinic Acid Dehydratase Polymorphism and Risk of Brain Tumors in Adults
The enzyme δ -aminolevulinic acid dehydratase (ALAD), which catalyzes the second step of heme synthesis, can be inhibited by several chemicals, including lead, a potential risk factor for brain tumors, particularly meningioma. In this study we examined whether the ALAD G177C polymorphism in the gene...
Autores principales: | Rajaraman, Preetha, Schwartz, Brian S., Rothman, Nathaniel, Yeager, Meredith, Fine, Howard A., Shapiro, William R., Selker, Robert G., Black, Peter M., Inskip, Peter D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280403/ https://www.ncbi.nlm.nih.gov/pubmed/16140629 http://dx.doi.org/10.1289/ehp.7986 |
Ejemplares similares
-
Role of δ-Aminolevulinic Acid Dehydratase (ALAD) gene polymorphism in lead induced nephrotoxicity
por: Tiwari, Mugdha, et al.
Publicado: (2014) -
Lead and δ-Aminolevulinic Acid Dehydratase Polymorphism: Where Does It Lead? A Meta-Analysis
por: Scinicariello, Franco, et al.
Publicado: (2007) -
Liver δ-Aminolevulinate Dehydratase Activity is Inhibited by Neonicotinoids and Restored by Antioxidant Agents
por: Sauer, Elisa, et al.
Publicado: (2014) -
Effects of δ‐aminolevulinic acid dehydratase silencing on the primary and secondary metabolisms of citrus
por: Killiny, Nabil, et al.
Publicado: (2018) -
Influence of gestational diabetes on the activity of
δ-aminolevulinate dehydratase and oxidative stress
biomarkers
por: Rodrigues, Fabiane, et al.
Publicado: (2017)